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Purpose: To decipher the transcriptional signature of macrophages of the human
vitreous, also known as hyalocytes, and compare it to the profiles of other
myeloid cell populations including human blood-derived monocytes, macrophages, and
brain microglia.
Methods: This study involves a total of 13 patients of advanced age with disorders
of the vitreoretinal interface undergoing vitrectomy at the University Eye Hospital
Freiburg between 2018 and 2019. Vitreal hyalocytes were analyzed by fluorescence-
activated cell sorting (FACS) and isolated as CD45+CD11b+CX3CR1+Mat-Mac+
cells using a FACS-based sorting protocol. RNA extraction, library preparation and
RNA sequencing were performed and the sequencing data was analyzed using the
Galaxy web platform. The transcriptome of human hyalocytes was compared to the
transcriptional profile of human blood-derived monocytes, macrophages and brain
microglia obtained from public databases. Protein validation for selected factors was
performed by immunohistochemistry on paraffin sections from three human donor eyes.
Results: On average, 383 ± 233 hyalocytes were isolated per patient, resulting in
128 pg/µl ± 76 pg/µl total RNA per sample. RNA sequencing revealed that SPP1, FTL,
CD74, and HLA-DRA are among the most abundantly expressed genes in hyalocytes,
which was confirmed by immunofluorescence for CD74, FTL, and HLA-DRA. Gene
ontology (GO) enrichment analysis showed that biological processes such as “humoral
immune response,” “leukocyte migration,” and “antigen processing and presentation
of peptide antigen” (adjusted p < 0.001) are dominating in vitreal hyalocytes. While
the comparison of the gene expression profiles of hyalocytes and other myeloid cell
populations showed an overall strong similarity (R2 > 0.637, p < 0.001), hyalocytes
demonstrated significant differences with respect to common leukocyte-associated
factors. In particular, transcripts involved in the immune privilege of the eye, such as
POMC, CD46, and CD86, were significantly increased in hyalocytes compared to other
myeloid cell subsets.
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GRAPHICAL ABSTRACT |
Conclusion: Human hyalocytes represent a unique and distinct innate immune cell
population specialized and adapted for the tissue-specific needs in the human vitreous.
Vitreal hyalocytes are characterized by a strong expression of genes related to antigen
processing and presentation as well as immune modulation. Thus, hyalocytes may
represent an underestimated mediator in vitreoretinal disease and for the immune
privilege of the eye.
Keywords: hyalocytes, vitreous macrophages, viterous body, innate immunity, myeloid cells, immune privilege
INTRODUCTION
In the course of evolution, the eye has developed a
unique relationship to the immune system, the so-called
immune privilege, which protects against immune-mediated
inflammatory damage, thus obtaining a free optical axis, and
preserving optimal vision (1). While the concept of the immune
privilege is simple, the study of its nature has revealed its highly
complex character. Several mechanisms, including local and
systemic responses, maintain in concert the privilege of the
ocular immune system. These include physical barriers such
as an efficient blood retina barrier and the lack of efferent
lymphatics, an inhibitory ocular microenvironment consisting of
soluble and cell-bound immunosuppressive factors, and finally
an active regulation of the systemic immune response [for a
detailed review see (1)]. The cellular mechanisms involved in
these processes, however, are not yet fully understood.
Vitreal macrophages, also known as hyalocytes, belong to
the family of resident innate immune cells in the posterior
eye segment and reside mainly in the posterior vitreous cortex
abutting the inner retinal surface (2). Although already first
described by Hannover in 1840 (3), little is known about the
biology and function of hyalocytes in the human eye. Hyalocytes
are relatively scarce and have long been regarded as resting cells.
In general, they have been studied less extensively compared to
other, more abundant intraocular cells, such as endothelial cells,
glia cells, or retinal pigmented epithelium (RPE). Recent evidence
indicates that hyalocytes actively contribute to the maintenance
of vitreous transparency, avascularity, and the synthesis of vitreal
extracellular matrix (ECM) proteins (4). Also, hyalocytes have
been postulated to inhibit intraocular inflammation, in order
to guarantee vitreous transparency, e.g., by contributing to the
vitreous cavity-associated immune deviation (VCAID), which
belongs to the unique mechanisms maintaining the immune
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privilege in the human eye (2, 5). Furthermore, macrophage-
like (6) hyalocytes are regarded as important modulators of
immunological and inflammatory processes within the vitreous
cavity and were suggested to play pivotal roles in pathological
conditions such as uveitis, proliferative diabetic retinopathy,
or proliferative vitreoretinopathy (2, 7). Animal studies show
that vitreal hyalocytes can migrate to sites of damage and
take part in immune response modulation during inflammation
(2, 8). However, these assumptions are merely based on pre-
clinical examinations and the exact molecular mediators, through
which hyalocytes modulate the human ocular immune privilege,
are still unknown.
In this study, we establish a fluorescence-activated cell
sorting (FACS)-based isolation protocol for human hyalocytes
in patients undergoing vitrectomy for vitreoretinal interface
diseases and provide an elaborated transcriptional profile of this
cell population, prior to comparing them to other myeloid cell
subtypes. We show for the first time that vitreal hyalocytes share
common myeloid cell markers but represent a distinct myeloid
cell subset with a unique transcriptional profile well-suited to
suppress ocular inflammation and immune reaction in the eye.
MATERIALS AND METHODS
Patients’ Characteristics
A total of 13 consecutive patients undergoing 23 gauge
vitrectomy for idiopathic macular pucker (MP, n = 7) or
idiopathic macular hole (MH, n = 6) in the University Eye
Hospital Freiburg between 2018 and 2019 were included in
this study (see Table 1). Patients with MP and MH were
treated with a meticulous removal of the vitreous body. The
epiretinal membrane (ERM) and the internal limiting membrane
(ILM) were removed in MP patients and the ILM only in MH
patients. Diagnosis was made based on a thorough funduscopic
exam and spectral domain optical coherence tomography
(HRA2, Heidelberg Engineering, Figure 1A). Only patients
with no history of previous vitreoretinal surgery, intraocular
TABLE 1 | Patients’ characteristics.




1 MP Yes Pseudophakic 291 142
2 MP No Pseudophakic 464 161
3 MP No Phakic 180 93
4 MH No Pseudophakic 315 301
5 MH Yes Phakic 550 110
6 MH No Phakic 164 174
7 MP No Pseudophakic 944 109
8 MH No Phakic 210 78
9 MP Yes Pseudophakic 186 26
10 MP No Phakic 306 240
11 MP No Pseudophakic 701 73
12 MH No Pseudophakic 240 78
13 MH No Phakic 424 73
inflammation, or concomitant vitreoretinal disease were included
in this study. Ethics approval was granted from the local Ethics
Committees and a written informed consent was obtained
from each patient.
FACS Sort
Vitreous tissue samples and the corresponding ERM and
ILM which are rich in hyalocytes (9, 10) were collected in
vitrectomy collection bags and immediately placed on ice in the
operating theater and processed for cell isolation within 2 h
of surgical resection. The content of each vitrectomy bag was
centrifuged for 10 min at 250 × g at 15◦C. After removing
the supernatant, the pellet was transferred to FACS tubes by
washing with phosphate-buffered saline (PBS) buffer (PAN)
and Hank’s balanced salt solution (HBSS, Gibco) and again
centrifuged for 10 min at 250 × g at 15◦C. The vitreous
pellet was digested with Collagenase D (5 mg/mL, Roche) and
DNase I (1 mg/mL, Roche) in HBSS for 20 min at 37◦C. Cells
were then filtered through a 70 µm cell strainer. Following
another centrifugation step (7 min at 250 × g at RT), 0.5 µL
of Fixable Viability Dye (eFluorTM 780, eBioscienceTM) per
1 mL of cells was added. The pellet was stained for CD45
(BV421, anti-human, 1:100, and BioLegend R©), CD11b (FITC,
anti-human, 1:100, and BioLegend R©), and CX3CR1 (PE-Cy7,
anti-human, 1:200, and BioLegend R©). To exclude any potential
contamination with blood-derived monocytes due to possible
surgically induced micro bleedings, we further used the Anti-
Human Mature Macrophages (MatMac) Antibody, an ED2-like
(ectodermal dysplasia 2) marker for resident macrophages, which
is absent in monocytes (11–14) (eFluor660, anti-human, 1:100,
and eBioscienceTM). After an incubation step of 20 min at 4◦C
cells were re-suspended in FACS buffer and processed for sorting
on the MoFlo Asrios EQ Cytometer (Beckman Coulter). Sorted
cells were stored in RNAprotect Cell Reagent (QIAGEN) at
2–8◦C until sequencing was performed.
Total RNA Extraction
RNA extraction, library preparation and RNA sequencing were
performed at the Genomics Core Facility “KFB – Center
of Excellence for Fluorescent Bioanalytics” (University of
Regensburg, Regensburg, Germany; www.kfb-regensburg.de).
In brief, total RNA was extracted from isolated hyalocytes
and stabilized in RNAprotect Cell Reagent according to the
RNeasy Plus Micro Kit protocol (QIAGEN). After pelleting, the
RNAprotect buffer was removed and replaced by RLT Plus buffer
and the samples homogenized by vortexing for 30 s. Genomic
DNA contamination was eliminated using gDNA Eliminator spin
columns. Next, ethanol was added and the samples were applied
to RNeasy MinElute spin columns followed by several wash steps.
Finally, total RNA was eluted in 12 µl of nuclease-free water.
RNA-Seq Libraries
In total 13 samples were analyzed using RNA sequencing. The
SMARTer Ultra Low Input RNA Kit for Sequencing v4 (Clontech
Laboratories, Inc.) was used to generate first strand cDNA from
750 pg total-RNA. Double-stranded cDNA was amplified by LD
PCR (12 cycles) and purified via magnetic bead clean-up. Library
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FIGURE 1 | Experimental Setup. (A) Study subjects were diagnosed by funduscopic examination and optical coherence tomography (SD-OCT). The arrow points at
a cell in the vitreous cavity of a patient with macular pucker, most likely one of a group of hyalocytes. (B) After performing a standard vitrectomy the content of a
single vitrectomy collection bag was treated according to a FACS protocol developed for the project, hyalocytes were sorted and then subjected to RNA sequencing
analysis. (C) Flow cytometric gating strategy for human hyalocytes characterized as CD45+CD11b+CX3CR1+MatMac+ cells. Cell populations were defined by
fluorescence intensity after exclusion of dead cells and doublets by viability dye and physical parameters (FSc, SSc): FSc, forward scatter; SSc, sideward scatter; H,
Height; and W, Width.
preparation was carried out as described in the Illumina Nextera
XT Sample Preparation Guide (Illumina, Inc.). 150 pg of input
cDNA were tagmented (tagged and fragmented) by the Nextera
XT transposome. The products were purified and amplified via a
limited-cycle PCR program to generate multiplexed sequencing
libraries. For the PCR step 1:5 dilutions of index 1 (i7) and
index 2 (i5) primers were used. The libraries were quantified
using the KAPA SYBR FAST ABI Prism Library Quantification
Kit (Kapa Biosystems, Inc.). Equimolar amounts of each library
were pooled, and the pools then used for cluster generation
on the cBot with the Illumina TruSeq SR Cluster Kit v3. The
sequencing run was performed on a HiSeq 1000 instrument using
the indexed, 50 cycles single-read (SR) protocol and TruSeq SBS
v3 Reagents according to the Illumina HiSeq 1000 System User
Guide. Image analysis and base calling resulted in bcl files, which
were converted into fastq files with the bcl2fastq v2.18 software.
The sequence data are available at the Gene Expression Omnibus
database under accession number GSE147657. The password is
available from the corresponding author upon request.
Bioinformatics
Sequencing data was analyzed on the Galaxy web platform
(usegalaxy.eu) (15). Quality control was performed with FastQC
Galaxy Version 0.72 (16). Sequencing adapter were trimmed
using Trim Galore! Galaxy Version 0.4.3.11, followed by quality
control with FastQC. Reads were mapped to the human reference
genome (Gencode, release 31, https://www.gencodegenes.org/
human/releases.html) with RNA STAR Galaxy Version 2.6.0b-
2 (default parameters) (17) using the Gencode annotation
file (Gencode, Release 31). Samples were then checked for
1https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/
contamination with rRNA using SortMeRNA Galaxy Version
2.1b.6 (18) as well as with non-human reads (bacteria, virus,
funghi, arachea, and protozoa) using RNA STAR Galaxy
Version 2.6.0b-2 (17). Reference genomes were downloaded from
NCBI FTP server (ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/,
Download between 6th and 13th July 2019).
Three BAM files for each sample (one for each lane) were
combined in one BAM file per sample using Convert, Merge,
Randomize BAM datasets Galaxy Version 2.4.0 (19). Reads
mapped to the human reference genome were counted using
featureCounts Galaxy Version 1.6.4 (default parameters) (20).
Samples with less than 10 million assigned reads were excluded
from further analysis. Next, we compared the human hyalocytes’
transcriptome to the transcriptional profile of human brain
microglia [raw data from (21), GEO accession: GSE99074,
samples with origin Netherlands], human macrophages and
monocytes [raw data from (22), GEO accession: GSE58310].
For analysis of the similarity between the four cell populations
the expression of each gene in each group was calculated
as a percentile. The similarity was defined as 1 min 1-
percentile. The Pearson coefficient R2 was used to quantify
the deviation from the diagonal with the incline 1, i.e., the
bigger R2 the stronger the similarity. Differential gene expression
was analyzed using DESeq2 Galaxy Version 2.11.40.6 (default
parameters) (23). Transcripts per million (TPM) were calculated
based on the output of featureCounts (assigned reads and
feature length), as described previously (24). The output of
featureCounts or DESeq2 was imported to RStudio (Version
1.2.1335, R Version 3.5.3). Genesymbols and genetypes were
determined based on ENSEMBL (download: 22.09.2019) (25).
Genes without a hit in the ENTREZ Gene (NCBI) search were
removed from analysis. Data visualization with volcano plots
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and MA plots was performed using the ggplot2 package (26).
Heatmaps were created with the R package ComplexHeatmap
1.20.0 (27). Gene enrichment analysis was performed using the R
package clusterProfiler 3.10.1 (28). Gene ontology (GO) analysis
for clusters related to biological processes (BP) was performed
based on the 100 highest expressed genes using the R function
enrichGO of the clusterProfiler package with default parameters.
Genes associated with the 5 most disease relevant BP were
illustrated using the R function cnetplot of the clusterProfiler
package with default parameters.
Immunohistochemistry
For immunohistochemical analysis, three randomly chosen and
macroscopically normal eyes from three body donors were
analyzed at the Institute of Anatomy at Leipzig University. Eyes
were enucleated in accordance with the consent of the body
donors, secured by contract during lifetime, and no data other
than age, sex, body weight, and cause of death were disclosed.
Following formalin fixation and paraffin embedding (FFPE),
human ocular donor samples were cut in 7 micrometer sections
and deparaffinized according to a standard protocol. Sections
were blocked with 2% bovine serum albumin (BSA) and 2%
normal goat serum (NGS) or normal donkey serum (NDS) in
PBS Triton-X 0.1% for 60 min at room temperature. Primary
antibodies against FTL (1:800, Sigma-Aldrich), CD74 (1:1000,
abcam), IBA1 (1:500, abcam), and HLA-DP, DQ, DR (1:200,
DAKO, clone CR3/43) were incubated in PBS containing 2% BSA
and 2% NGS (CD74 and FTL), or NDS (IBA1, HLA-DP, DQ,
and DR) in PBS Triton-X 0.1% overnight at 4◦C. The primary
antibody was omitted for negative control. Following extensive
washing with 2% BSA and 0.2% NGS/NDS in PBS Triton-
X 0.1%, sections were incubated with an Alexa Fluor R© 568-
labeled donkey anti-mouse, Alexa Fluor R© 647-labeled donkey
anti-goat or Alexa Fluor R© 647-labeled goat anti-rabbit secondary
antibody 1:500 in PBS Triton-X 0.1% (Thermo Fisher Scientific)
at room temperature for 90 min in the dark. After washing
at least three times with 2% BSA and 0.2% NGS/NDS in PBS
Triton-X 0.1%, slides were counterstained with 4′,6-Diamidin-2-
phenylindol (DAPI) 1:10000 for 10 min, washed three times with
PBS followed by autofluorescence quenching with TrueBlack R©
Lipofuscin Autofluorescence Quencher (Biotium) according to
the manufacturers’ instructions. Slides were imaged using a
confocal Fluoview FV1000 (Olympus) equipped with a 0.75 NA U
Plan S Apo 20x and 40x 0.95 NA U Plan S Apo 40X2 (Olympus).
RESULTS
Patients
A total of 13 patients undergoing vitrectomy for macular pucker
(MP, n = 7, mean age 73 ± 3.7 years) or macular hole (MH,
n = 6, mean age 73 ± 9.7 years, p = 0.833) were included in
the study (Table 1). All patients revealed idiopathic ERMs or
full-thickness macular holes on SD-OCT (Figure 1A). Posterior
vitreous detachment (PVD) was present in 3 out of 13 patients
prior to surgery and had to be induced in the remaining 10
patients intraoperatively.
FACS-Based Characterization and
Isolation of Human Hyalocytes
Fluorescence-activated cell sorting characterization revealed
that hyalocytes express the pan-leukocyte marker CD45 and
characteristic myeloid cell markers including CD11b and
CX3CR1 beside the macrophage-specific marker MatMac
(Figure 1C). Based on the observed staining pattern, hyalocytes
were defined as CD45+CD11b+CX3CR1+MatMac+ cells and
isolated by flow cytometry (Figures 1B,C). The cell number
of isolated hyalocytes ranged from 180 to 944 per vitrectomy
collection bag in patients with macular pucker (average 438.9)
and 164 to 550 cells in patients with macular hole (average
317.2, p = 0.351; Table 1). The mean concentration of extracted
RNA of the isolated hyalocytes was similar in patients with
macular pucker (120.6 pg/µL, 26–240 pg/µL) and macular hole
(135.7 pg/µL, 73–301 pg/µL, and p = 0.744; Table 1).
Transcriptional Profiling of Human
Hyalocytes
Following RNA-Seq a mean total number of 36.8 million
raw reads (25.2–47.7) per sample was obtained from isolated
CD45+CD11b+CX3CR1+MatMac+ cells. Four samples [from
three patients with MP (patients #3, 9, and 10) and one patient
with MH (patient #8)] were excluded due to a low number
of assigned reads. Hierarchical clustering of expressed genes
from all hyalocytes revealed no strong patterns that were related
to diagnosis, sex or age (Supplementary Figures S1A,B). The
expression profile of vitreal hyalocytes in patients with macular
pucker or macular hole (Supplementary Figure S1A) was very
similar (Supplementary Figure S1B) and only a negligible
number of transcripts were differentially expressed between these
two groups (Supplementary Figures S1C,D). The comparable
transcriptional profile of hyalocytes derived from eyes with
macular pucker and macular hole (Supplementary Figures S1B–
D) implies no or at least a similar affection of hyalocytes due to
the underlying vitreoretinal interface pathology. This prompted
us to process the samples together for further analysis.
Relative expression values for the 30 most strongly represented
transcripts common to all samples demonstrated that human
hyalocytes express high levels of numerous genes associated with
antigen presentation, including CD74, HLA-DRA, and HLA-
DRB1, regulation of myeloid cell migration and chemotaxis,
such as TREM2, CXCL8, CCL2, and humoral immune response,
e.g., C1QA, C1QB, and LYZ (Figures 2A–C and Supplementary
Figure S3A). Other genes are associated with a myeloid gene
expression signature including TYROBP encoding the adaptor
molecule DAP12 associated with both TREM2 and the colony-
stimulating factor 1 receptor (CSF1R) essential for mediating
macrophage survival pathways (Figure 2A). According to
mean TPM in all samples, SPP1 (secreted phosphoprotein
1) is the most prominent transcript in human hyalocytes
(44917.0 TPM), followed by FTL (ferritin light chain, 37850.2
TPM), CD74 (Cluster of differentiation 74, 25094.1 TPM),
ACTB (beta actin, 23141.3 TPM), PSAP (prostatic specific acid
phosphatase, 17229.7 TPM), and FOS (Fos proto-oncogene,
11907.0 TPM; Figure 2A). Furthermore, human hyalocytes
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FIGURE 2 | High throughput sequencing characterization of human hyalocytes. (A) Heatmap of the most prominent transcripts in human hyalocytes sorted by
transcripts per million (TPM). The color bars on the top of the heatmap reveal diagnosis of study subjects (pink for macular pucker, lilac for macular hole), sex
(grass-green for male, orange for female), and age (age scale bar legend to the right). (B) Most significant Gene ontology biological process (BP) clusters of the 100
most highly expressed mRNA transcripts in hyalocytes. Color coding of the dots according to the p-adjusted value, size of the dots according to the count of
transcripts associated with the respective GO term. (C) Top five most highly expressed transcripts in the five enriched GO terms in B. (D) Immunohistochemical
staining for FTL. Higher magnification of a vitreal cell is presented in the upper right corner. Nuclei are counterstained with DAPI (4’,6-Diamidin-2-phenylindol). DIC,
differential interference contrast; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; and RPE, retinal pigment epithelium.
(E) Immunohistochemical staining for CD74. Higher magnification of a vitreal cell is presented in the upper right corner. Nuclei are counterstained with DAPI
(4’,6-Diamidin-2-phenylindol). DIC, differential interference contrast; GCL, ganglion cell layer; INL, inner nuclear layer; and ONL, outer nuclear layer.
Frontiers in Immunology | www.frontiersin.org 6 September 2020 | Volume 11 | Article 567274
fimmu-11-567274 September 10, 2020 Time: 19:36 # 7
Boneva et al. Transcriptional Signature of Human Hyalocytes
express numerous common leukocyte-associated genes, such
as PTPRC (CD45), ITGAL (CD11a), and ITGB2 (CD18), or
preferentially in myeloid cells, e.g., ITGAM (CD11b), CD14, and
FCGR1A (CD64) supporting the notion of a myeloid-cell derived
origin (Supplementary Figure S2). In addition, a plethora
of factors involved in vitreous metabolism were found to be
strongly expressed in hyalocytes in our analysis (Supplementary
Figure S3). For a full list of genes expressed in hyalocytes refer to
Supplementary Table S1.
Biological Pathways and Molecular
Functions of Human Hyalocytes
To gain more insight into the biological pathways and molecular
functions (MF) hyalocytes are involved in, we performed a
GO cluster analysis of the top 100 most highly expressed
genes in hyalocytes. GO enrichment analysis of BP showed
that hyalocytes express genes that are involved in “humoral
immune response” (GO:0006959), “leukocyte chemotaxis
and migration” (GO:0030595 and GO:0050900), “myeloid
leukocyte migration” (GO:0097529), and “antigen processing
and presentation of peptide antigen” (GO:0048002; adjusted
p < 0.00, Figure 2B, and Supplementary Figure S4A). CD74
was the most highly expressed factor in two of the most enriched
clusters (Figure 2C). When sorted according to the lowest
adjusted p value, the GO enrichment analysis revealed MF such
as “amide and peptide binding” (GO:0033218 and GO:0042277),
“amyloid-beta binding” (GO:0001540), “MHC class II protein
complex binding” (GO:0023026), and “MHC protein complex
binding” (GO:0023023) to be the most enriched in hyalocytes
(Supplementary Figure S4B and Supplementary Table S3).
All top expressed genes enriched in the 5 most relevant GO BP
and MF terms are illustrated in the cnetplots in Supplementary
Figure S4 and summarized in Supplementary Tables S2, S3.
CD74 and FTL Expression in Human
Hyalocytes
Our RNA-Seq analysis revealed that both FTL and CD74 are
strongly expressed in human hyalocytes. To validate these
findings on a protein level we assessed FTL and CD74
localization by immunofluorescence microscopy in human
body donor eyes. In healthy eyes, hyalocytes could be
clearly identified in the vitreous by differential interference
contrast (DIC) and we observed a strong FTL and CD74
immunofluorescent signal in these cells (Figures 2D,E, negative
controls omitting the primary antibody are provided in
Supplementary Figure S5A). More hyalocytes positive for CD74
are shown in Supplementary Figure S6A.
Transcriptome Comparison of
Hyalocytes and Other Myeloid Cell Types
Immunohistochemical studies (29) and our sequencing data
(Supplementary Figure S2) indicate that vitreal hyalocytes
belong to the myeloid cell lineage. To determine potential
similarities and differences between hyalocytes and other myeloid
cell populations, we conducted a detailed comparison of the
hyalocyte transcriptome with published RNA sequencing profiles
of human brain microglia, human monocytes and monocyte-
derived macrophages obtained from public databases. A first
assessment of the data in a principal component analysis
(PCA) showed that the transcriptional profile of hyalocytes is
distinct from the one of microglia, macrophages, and monocytes
(Figure 3A). Hierarchical clustering analysis of all expressed
genes in the four cell types is illustrated in Figure 3B,
showing considerable cell-dependent gene expression patterns.
However, no obvious difference was found in the expression
profiles of hyalocytes in patients with macular pucker and
macular hole (Figures 3A,B and Supplementary Figure S1).
To analyze the level of similarity between the four groups,
we correlated the transcriptional profile of hyalocytes with the
profiles of the other groups. We found a robust correlation
between the transcriptional profiles of hyalocytes and blood-
derived monocytes (R2 = 0.63, p < 0.001), brain microglia
(R2 = 0.68, p < 0.001) and, most pronounced, macrophages
(R2 = 0.75, p < 0.001, Figure 3C), indicating a general
similarity in the patterns of gene expression and thus close
relationships. However, when focusing on distinct myeloid
cell markers, we found considerable differences, indicating
tissue- and cell-specific immunogenic properties of the myeloid
cell subsets. While CX3CR1 or FCGR1A (CD64) were highly
and similarly expressed in hyalocytes and brain microglia,
they were barely detectable in macrophages and monocytes
(Supplementary Figure S2). Expression of HLA-DRA (MHCII)
molecules and CD14, in contrast, was remarkably increased
in hyalocytes compared to a low expression in microglia,
macrophages or monocytes (Supplementary Figure S2). On
the other hand, CD11b expression was significantly reduced in
hyalocytes compared to microglia, macrophages or monocytes
(Supplementary Figure S2). Interestingly, SALL1 expression
was, as expected, high in microglia but almost not detectable
in hyalocytes, macrophages, or monocytes (Supplementary
Figure S2). Furthermore, we found 91 collectively upregulated
genes in hyalocytes compared with other myeloid cell subsets.
Among these factors, CD74, SPP1, ACTB, FOS, and MHCII-
related genes such as HLA-DRA emerged as the transcripts
with the highest log2 fold change in comparison to the other
cell types (Figures 3D,E). Immunohistochemical staining for
HLA-DRA and IBA1 (ionized calcium-binding adapter molecule
1) revealed that hyalocytes express HLA-DRA on the protein
level, while microglia cells were at most slightly positive for
HLA-DRA, but positive for IBA1 supporting our sequencing
data (Figure 3F and Supplementary Figure S6B). Negative
controls omitting the primary antibodies are provided in
Supplementary Figure S5B. These data indicate that hyalocytes
express numerous myeloid cell markers underscoring their
common myeloid cell identity, but at the same time are
characterized by a distinct immune cell profile specialized and
adapted for the tissue-specific environment.
Immune Privilege Factors Expression in
Hyalocytes
To determine if hyalocytes contribute to the expression of factors
that have been associated with the immune privilege of the
Frontiers in Immunology | www.frontiersin.org 7 September 2020 | Volume 11 | Article 567274
fimmu-11-567274 September 10, 2020 Time: 19:36 # 8
Boneva et al. Transcriptional Signature of Human Hyalocytes
FIGURE 3 | Continued
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FIGURE 3 | The transcriptional profile of human hyalocytes differs significantly from other myeloid cell populations. (A) Principal component analysis (PCA) plot
illustrating the distribution of the four analyzed populations. Hy, hyalocytes; Mac, macrophages; BrMG, brain microglia; Mono, monocytes; MP, macular pucker; and
MH, macular hole. (B) Unsupervised heatmap showing the transcriptional profile of hyalocytes, macrophages, brain microglia, and monocytes (all genes of all data
sets). Rows and columns are clustered according to similarity of the expression. The color bars on the top of the heatmap reveal cell type (hyalocytes in light blue,
macrophages in dark blue, brain microglia in light green, and monocytes in dark green), diagnosis of study subjects (pink for macular pucker, lilac for macular hole),
sex (grass-green for male, orange for female), and age (age bar on the right side). Color coding of the transcripts according to the z-score (deviation from a gene’s
mean expression in standard deviation units). Hy, hyalocytes; Mac, macrophages; BrMG, brain microglia; Mono, monocytes; MP, macular pucker; MH, macular hole;
and NA, not applicable. (C) Graphical presentation of the percentiles of normalized counts to illustrate the similarity between the transcriptomes of monocytes
(Mono) and hyalocytes (Hy), brain microglia (BrMG), and hyalocytes or macrophages (Mac) and hyalocytes. The expression of each gene in each cell population was
calculated as a percentile (the gene with the highest mean of normalized counts getting the percentile 100, the one with the lowest – the percentile 0). Colors code
for the similarity defined as 1 min 1 percentile. The Pearson coefficient R2 quantifies the deviation from the diagonal with the incline 1. The higher R2, the higher the
similarity between the two compared cell populations. (D) Top 20 most highly expressed genes in human hyalocytes (Hy). Transcripts are sorted according to their
expression level in hyalocytes (mean normalized reads counts, black dot, and upper x-axis). The color bars code for the log2 fold change (lower x-axis) of the
upregulated transcripts in hyalocytes in comparison to monocytes (dark green), brain microglia (light green), and macrophages (blue). The dashed red line
distinguishes the log2FC of 2, according to which factors are defined as differentially upregulated. (E) Box plots, illustrating the normalized reads count of CD74,
SPP1, ACTB, and HLA-DRA in hyalocytes (Hy), macrophages (Mac), brain microglia (BrMG), and monocytes (Mono). (F) Immunohistochemical staining for HLA-DRA
and IBA1. A vitreal cell is presented in higher magnification in the upper right corner. Higher magnification of the section within the dashed white square in the lower
panel. The lumen of an intraretinal vessel is traced with the white dashed line. The arrow points at a perivascular macrophage, the arrow head to an intraluminal
leukocyte, the asterisk is positioned between two microglial cells (positive for IBA1). Nuclei are counterstained with DAPI. DIC, differential interference contrast; GCL,
ganglion cell layer; IPL, internal plexiform layer; and INL, inner nuclear layer.
FIGURE 4 | Immunomodulatory transcripts in human hyalocytes and other myeloid cells. (A) Heatmap representing the expression pattern of 40 established immune
privilege factors in hyalocytes (Hy, light blue), macrophages (Mac, dark blue), brain microglia (BrMG, light green), and blood-derived monocytes (Mono, dark green).
(B) Boxplots illustrating the expression of POMC, CD46, CD86, TGFB2, and HLA-DMA in hyalocytes (Hy, light blue box), macrophages (Mac, dark blue box), brain
microglia (BrMG, light green box), and blood-derived monocytes (Mono, dark green box).
eye, we next explored the expression pattern of 60 established
immune privilege factors (30–36) in hyalocytes, macrophages,
brain microglia, and blood-derived monocytes (Figure 4A). In
contrast to the other myeloid cell subsets, hyalocytes expressed
immunosuppressive factors, such as POMC, CD46, and CD86
indicating that hyalocytes contribute to the immunosuppressive
environment in the eye. TGFB2, a well-known immune privilege
factor in the eye (36), was expressed in hyalocytes to a
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similar extent as in microglia and more abundantly compared
to macrophages. Interestingly, hyalocytes abundantly expressed
MHCII-related genes such as HLA-DRA, HLA-DMA, and HLA-
DMB, supporting the notion that hyalocytes are antigen-
presenting cells (APCs; Figure 4B).
DISCUSSION
In 1874, the so-called “subhyaloidal cells” were already assumed
to have macrophage characteristics (37). More than 100 years
later, vitreal hyalocytes were characterized as macrophage-like
cells with phagocytic properties and receptors for IgG and
complement factors on their surface (38). Due to their scarcity
vitreal hyalocytes have eluded comprehensive investigation in
the past (39). In particular, the transcriptional profile and the
exact function of hyalocytes remain unknown to date. In this
study, we devised a protocol to isolate hyalocytes from patients
with vitreoretinal interface disease, deciphered the hyalocyte
transcriptional profile using RNA sequencing and compared it to
reported transcriptomes of other myeloid cell subsets including
monocytes, macrophages, and microglia. We show that vitreal
hyalocytes share common myeloid cell markers but at the same
time represent a unique myeloid cell subset with a specialized
transcriptional signature, which may contribute to reducing
ocular inflammation and immune responses in the eye.
Morphological studies using light and electron microscopy
have demonstrated that hyalocytes are morphologically very
similar to cells of the monocyte/macrophage lineage (29, 40).
The hypothesis that hyalocytes originate from the myeloid
cell lineage has been supported by immunohistochemical
studies demonstrating CD45, CD64, CD11a, and major
histocompatibility complex (MHC) class II expression in this
cell type (29). In line with these observations, our transcriptional
analysis strongly supports a myeloid cell identity. The GO
enrichment analysis revealed BP contributing to “innate immune
responses” and “antigen processing and presenting processes”
as highly enriched in hyalocytes. In more detail, hyalocytes
expressed common leukocyte-associated genes such as PTPRC
(CD45), ITGAL (CD11a), Cx3CR1, FCGR1A (CD64), CD163, and
genes encoding for the major histocompatibility complex class
II, which supports previously published immunohistochemical
studies (29). Interestingly, hyalocytes express very little CD68,
which is also consistent with earlier reports (29), but remarkable
since CD68 is regarded as a selective marker for monocytes and
tissue macrophages (41).
Beyond the already known factors involved in hyalocyte
biology, our sequencing analysis revealed a plethora of strongly
expressed factors which so far were unknown in hyalocytes. These
most abundantly expressed genes in hyalocytes were strikingly
similar to the top expressed transcripts in brain microglia
indicating a close relationship between both populations (42).
Among them SPP1, CD74, and FTL emerged as the most
prominent factors expressed in human hyalocytes and brain
microglia (42). The SPP1 gene encodes for the secreted
phosphorylated glycoprotein Osteopontin (OPN). It is implicated
in various immune processes in neurodegenerative disease (43)
and has an essential role in the interaction between the innate
and adaptive immune system (44, 45). In the human eye
SPP1 is distributed in the aqueous humor (AqH) (46) and
the vitreous fluid (47) and reported to mediate photoreceptor
survival in experimental models for retinal degeneration (48).
Our results demonstrate that human hyalocytes represent a
source for SPP1 expression in the posterior segment of the
eye where it may act as a neuroprotective molecule for retinal
homeostasis. Ferritin light chain (FTL), on the other hand,
encodes the light subunit of the ferritin protein (49), the main
iron storage in the human body, which has been linked to
anti-inflammatory responses in murine macrophages (50) and
neurodegeneration in mice (51). The vitreous humor of patients
with vitreoretinal diseases has been shown to contain more
iron than a healthy vitreous, leading to various complications
due to an increased susceptibility to oxidative damage (52).
FTL in hyalocytes may therefore act in neuroprotective iron
reduction of vitreous iron levels. Finally, CD74 (Cluster of
differentiation 74) is a transmembrane glycoprotein, which acts
as MHC class II chaperone regulating T- and B-cell development,
innate immune cell motility and inflammatory processes (53).
CD74 is a high affinity receptor for MIF (macrophage migration
inhibitory factor) on APCs and implicated in a number of
inflammatory processes in neurodegenerative affections such
as Alzheimer’s disease (54). In the eye, increased levels of
soluble CD74 and MIF have been detected in the vitreous and
in endothelial and stromal cells in neovascular membranes of
patients with proliferative diabetic retinopathy suggesting that
MIF-CD74 signaling is implicated in disease progression (55).
Hyalocytes expressing CD74, as shown in this study, may thus be
an additional cellular target for MIF signaling which may induce
a pro-inflammatory cell phenotype. These hypotheses need to
be investigated in further in vivo studies to determine the exact
function of these factors in hyalocytes and to define hyalocyte-
specific markers that will enable future tracing of hyalocytes in
neurodegenerative eye disease.
Since hyalocytes belong to the innate immune system and have
been reported to be potential candidates for inhibiting intraocular
inflammation to maintain vitreous transparency, it is tempting to
speculate about their role in the ocular immune privilege. Our
study demonstrates that hyalocytes express a variety of factors
which are known to play a key role in the immune privilege
of the eye, including α-melanocyte-stimulating hormone (α-
MSH), CD86, CD46, and TGFβ2, just to name a few. In the
ocular microenvironment, and in the vitreous body in particular,
hyalocytes or any other potential APCs are exposed to a number
of immune-modulating molecules that are either stimulatory
or suppressive. Animal studies suggest that TGFβ2 (56, 57)
and α-MSH (58, 59) are the dominant immunosuppressive
factors which suppress the generation of Th1-responses and the
inflammatory activity of innate immune cells, e.g., by inhibiting
their production of IL-12 (57). The human AqH is rich in TGF-
β2, α-MSH and vasoactive intestinal peptide (60) and it has been
postulated these factors mediate the ocular immune privilege
by inducing regulatory T-cells (61, 62). Our study demonstrates
that vitreal hyalocytes strongly transcribe TGFβ2 and α-MSH
and much less IL-12, which suggests that hyalocytes are a source
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of immune-suppressive factors and contribute to the ocular
immune privilege.
Furthermore, the ocular immune privilege is achieved in
part by molecules that typically have a role in immune co-
stimulation. For example iris and ciliary body pigmented
epithelial cells express cell surface CD86, thus preventing T-cells
from proliferating and secreting cytokines through direct cell-
to-cell contact (63, 64). Conversely, myeloid dendritic cells
isolated from uveitic AqH were characterized by elevated
major histocompatibility complex classes I and II (MHC
I/II), but reduced CD86 compared to matched peripheral
blood dendritic cells (65). CD86 expression in hyalocytes
may thus serve as an additional protective immunosuppressive
mechanism to reduce T-cell activation in the steady state
to prevent leakage of cells and proteins into the optically
clear vitreous. Future studies are needed to investigate how
the above-mentioned immunosuppressive properties can be
brought together with the high expression of antigen-presenting
molecules in hyalocytes, such as MHCII, which are classically
considered pro-inflammatory. One explanation may be that
hyalocytes capture antigens in the vitreous cavity and present
them to natural killer T cells in the spleen, thus inhibiting
intraocular inflammation, as described in preclinical models for
VCAID (2, 5).
Last but not least, human tissue and organs are protected
from the autologous complement system through the activity of
membrane regulatory proteins, such as the membrane cofactor
protein (MCP, CD46) (66). CD46 is expressed ubiquitously in
humans and functions as a key regulator of the alternative
complement pathway and a co-factor in the factor I-mediated
proteolytic cleavage of C3b and C4b. Also, it is responsible
for the suppression of adaptive T helper type 1 (Th1) immune
responses by regulating the production of interferon (IFN)-γ
versus interleukin (IL)-10 within these cells. Sohn and colleagues
(66) have shown that the soluble form of CD46 is present in
normal human vitreous. They hypothesize that the expression
of CD46 in retinal cells is polarized toward the outer limiting
membrane end of Müller cells. In this study we provide an
alternative explanation, and reveal vitreal hyalocytes as a possible
source of CD46 production which may mediate a suppression
of the alternative complement factor, thereby contributing to an
immune privileged microenvironment.
Besides their function in modulation of ocular inflammation,
hyalocytes are involved in ECM synthesis (2). In line with this
assumption, we found a strong expression of genes involved in
the formation of proteoglycans, such as versican (VCAN), and
several collagen types, such as COL5A1 and COL9A2, in our
analysis. Furthermore, Fibronectin, which is suggested to play a
role in attaching the vitreous to the ILM (67), was among the
most strongly represented ECM factors in our analysis. Although
hyalocytes are located in the region with the highest hyaluronan
concentration in the vitreous (68), our analysis showed that
hyalocytes are not actively engaged in hyaluronan synthesis.
Interestingly, enzymes, important for hyaluronan degradation,
such as hyaluronidases (e.g., HYAL2), were found to be strongly
expressed in our samples, which is in line with previous
reports (69).
We acknowledge that our study has some limitations, which
include the fact that hyalocytes were obtained from patients of
advanced age with vitreoretinal disease, namely macular hole or
macular pucker. However, since both conditions are disease of
the posterior pole and represent a frequent consequence of PVD,
we assume that hyalocytes in these conditions represent the most
physiological state clinicians can access. Furthermore, hyalocytes
of macular pucker and macular hole vitreous bodies are similar
on a transcriptional level indicating that the disease itself does
not affect hyalocyte RNA expression patterns or yet affects them
in a similar way. Since mRNA degradation occurs within a few
hours (70, 71), we did not attempt to analyze hyalocytes from post
mortem eyes, in which the typical death to preservation time is in
a range of more than 24 h (72).
In summary, this study reports on the first transcriptional
profile of human hyalocytes obtained from patients with
vitreoretinal interface disease. Vitreal hyalocytes share common
myeloid cell markers, but represent a distinct myeloid cell
subset with a unique transcriptional profile. Our data suggest
that hyalocytes contribute to the ocular immune privilege
and modulate vitreoretinal disease, thus deserving further
scientific scrutiny.
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FIGURE S1 | Transcriptional analysis does not reveal significant differences of
hyalocytes from macular pucker and macular hole eyes. (A) 13 patients
undergoing vitrectomy for macular pucker (right-hand side panel) or macular hole
(left-hand side panel) were included in this study. (B) Heatmap depicting the
transcriptional profile of the 13 samples. The color bars on the top of the heatmap
reveal diagnosis of study subjects (pink for macular pucker, lilac for macular hole),
sex (grass-green for male, orange for female), and age (age bar on the right side).
Color coding according to the z-score (deviation from a gene’s mean expression in
standard deviation units). The transcripts are sorted according to the normalized
counts (log2-scaled). (C) Volcano plot illustrating the genes differentially expressed
between hyalocytes in macula pucker and macular hole patients [log2FC < -2
and > 2 (positive log2FC referring to macular hole samples), p-value < 0.05]. The
darker colored genes are filtered for StdErr ≤ 1. (D) Graphical presentation of the
percentiles of normalized counts to illustrate the similarity between the
transcriptomes of maclar pucker (MP) and macular hole (MH) eyes. The
expression of each gene in each cell population was calculated as a percentile
(the gene with the highest mean of normalized counts getting the percentile 100,
the one with the lowest – the percentile 0). Colors code for the similarity defined as
1 min 1 percentile. The Pearson coefficient R2 quantifies the deviation from the
diagonal with the incline 1.
FIGURE S2 | Hyalocytes express numerous leucocyte-associated transcripts.
Box plots, illustrating the normalized reads count PTPRC (CD45), ITGAL (CD11a),
CX3CR1, HLA-DRA, SALL1, ITGB2 (CD18), HEXB, CD14, CD68, FCGR1A
(CD64), and ITGAM (CD11b) in hyalocytes (Hy), macrophages (Mac), brain
microglia (BrMG), and monocytes (Mono).
FIGURE S3 | Hyalocytes express numerous factors involved in vitreous
homeostasis. Heatmap depicting the expression of genes coding for extracellular
matrix proteins in hyalocytes (Hy) and microglia (BrMG). The transcripts are sorted
according to the normalized counts (log2-scaled). Significance level for the
comparison is shown in the bar on the right side, red coding for a significantly
higher expression in human hyalocytes.
FIGURE S4 | Biological processes and molecular functions of human hyalocytes.
All top expressed genes enriched in the 5 most disease-relevant GO biological
processes (BP, A) and molecular functions (MF, B) terms are illustrated in
cnetplots.
FIGURE S5 | Negative controls for immunohistochemistry. Negative controls were
performed by omitting primary antibodies. (A) Negative control for FTL and CD74
immunohistochemical stainings shown in Figures 2D,E. Nuclei are counterstained
with DAPI. GAR647, goat anti-rabbit Alexa Fluor 647. (B) Negative control for
HLA-DRA and IBA1 immunohistochemical staining shown in Figure 3F. Nuclei are
counterstained with DAPI. DAM568, donkey anti-mouse Alexa Fluor 568.
DAG647, donkey anti-goat Alexa Fluor 647.
FIGURE S6 | Immunohistochemical stainings for CD74 (A) and HLA-DRA (B). The
arrows point at vitreal cells positive for CD74 (first and second row in A) or
HLA-DRA (B). Vitreal cells are presented in higher magnification in the upper right
corner (third and fourth row in A). Nuclei are counterstained with DAPI. DIC,
differential interference contrast; GCL, ganglion cell layer; INL, inner nuclear layer;
and ONL, outer nuclear layer.
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